Showing 15,381 - 15,400 results of 121,820 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 1.74s Refine Results
  1. 15381
  2. 15382
  3. 15383

    Key safety measures including adverse events. by Anuja Dokras (8679261)

    Published 2025
    “…Of the 240 participants randomly assigned, 20 out of 79 in the COCP group, 16 out of 81 in the metformin group, and 17 out of 80 in the combined group dropped out of the study. A total of 169 participants (70.4%) completed the trial between January 2018 and June 2023 (mean age: 29.5 years; mean BMI: 35.6 kg/m<sup>2</sup>; 70% were White and 23% were Black). …”
  4. 15384
  5. 15385
  6. 15386
  7. 15387
  8. 15388
  9. 15389
  10. 15390
  11. 15391
  12. 15392
  13. 15393
  14. 15394

    TOP2α/170 mRNA and protein levels in K562, drug resistant K/VP.5, and K562/SSedit-2 cells. by Victor A. Hernandez (12647320)

    Published 2022
    “…Using a two-tailed Student’s <i>t</i> test comparing the differences in mean calculated 2<sup>-ΔCt</sup> values: <i>P</i> <0.001 for K/VP.5 vs. …”
  15. 15395
  16. 15396
  17. 15397

    Change of SMAD4 after TGFβ inhibitor /activator treatment. by Jingping Ge (636557)

    Published 2015
    “…Protein levels were measured by Western blot analysis. A) Decrease of total p-SMAD2 after SB431542 treatment in all iPSCs, and increase of p-SMAD2 in both DBA iPSCs after the TGFβ1 treatment. …”
  18. 15398

    FOXO3a mediates the downregulation of GR induced by chronic exposure to GCs. by Shi-Ying Yuan (2937669)

    Published 2016
    “…<p>(A) Representative western blot images and summarized data showing the decreased expression of LKB1 (A) and the inhibitory phosphorylation of FOXO3a-Thr32 (B) in cultured astrocytes (n = 6 for each group). …”
  19. 15399
  20. 15400